http://orcid.org/0000-0001-5936-4050
Figures
Abstract
Background
The role of timing and diversity of allergenic food introduction in the development of childhood allergic sensitization and atopic diseases is controversial.
Objective
To examine whether timing and diversity of allergenic food introduction are associated with allergic sensitization, allergy and eczema in children until age 10 years.
Materials and methods
This study among 5,202 children was performed in a population-based prospective cohort. Timing (age ≤6 months vs. >6 months) and diversity (0, 1, 2 and ≥3 foods) of allergenic food (cow's milk, hen's egg, peanut, tree nuts, soy and gluten) introduction were assessed by questionnaires at ages 6 and 12 months. At age 10 years, inhalant and food allergic sensitization were measured by skin prick tests, and physician-diagnosed inhalant and food allergy by questionnaire. Data on parental-reported physician-diagnosed eczema were obtained from birth until age 10 years.
Results
Children introduced to gluten at age ≤6 months had a decreased risk of eczema (aOR (95% CI): 0.84 (0.72, 0.99)), compared with children introduced to gluten at age >6 months. However, timing of allergenic food introduction was not associated with allergic sensitization or physician-diagnosed allergy. Children introduced to ≥3 allergenic foods at age ≤6 months had a decreased risk of physician-diagnosed inhalant allergy (0.64 (0.42, 0.98)), compared with children not introduced to any allergenic food at age ≤6 months. However, diversity of allergenic food introduction was not associated with allergic sensitization, physician-diagnosed food allergy or eczema.
Citation: Elbert NJ, Kiefte-de Jong JC, Voortman T, Nijsten TEC, de Jong NW, Jaddoe VWV, et al. (2017) Allergenic food introduction and risk of childhood atopic diseases. PLoS ONE 12(11): e0187999. https://doi.org/10.1371/journal.pone.0187999
Editor: Lucienne Chatenoud, Université Paris Descartes, FRANCE
Received: August 16, 2017; Accepted: October 30, 2017; Published: November 27, 2017
Copyright: © 2017 Elbert et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The data for this study were obtained from Generation R Study, a large birth cohort in Rotterdam, The Netherlands. Due to ethical and legal restrictions, individual researchers do not have the right to distribute data from the Generation R Study. Interested qualified researchers may request the data by contacting our data manager Claudia J. Kruithof (c.kruithof@erasmusmc.nl or datamanagementgenr@erasmusmc.nl) and the director of the Generation R Study Vincent Jaddoe (v.jaddoe@erasmusmc.nl). Data will be made available via these contact persons after written agreement about the use of the data via the Technology Transfer Office of the Erasmus Medical Center. Co-authorship is not required in order to gain access to the data set.
Funding: The Generation R Study is made possible by financial support from the Erasmus MC, Rotterdam, the University Medical Center Rotterdam and the Netherlands Organization for Health Research and Development. Jessica Kiefte-de Jong and Trudy Voortman work in ErasmusAGE, a research center that receives funding from Nestlé Nutrition (Nestec Ltd.), and Metagenics Inc. Vincent Jaddoe received an additional grant from the Netherlands Organization for Health Research and Development (ZonMw- VIDI). Liesbeth Duijts received additional funding from the co-funded programme ERA-Net on Biomarkers for Nutrition and Health (ERA HDHL) (ALPHABET project, Horizon 2020 (grant agreement No 696295; 2017), Netherlands Organization for Health Research and Development (No 529051014; 2017), Science Foundation Ireland (No SFI/16/ERA-HDHL/3360), and the European Union). The project received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 733206 (LIFECYCLE). The researchers are independent from the funders. The funders had no role in the study design, data collection, data analysis, interpretation of data, and preparation, review or approval of the manuscript.
Competing interests: The Generation R Study is made possible by financial support from the Erasmus MC, Rotterdam, the University Medical Center Rotterdam and the Netherlands Organization for Health Research and Development. Jessica Kiefte-de Jong and Trudy Voortman work in ErasmusAGE, a research center that receives funding from Nestlé Nutrition (Nestec Ltd.), and Metagenics Inc. There are no patents, products in development or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Abbreviations: aOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; IgE, immunoglobulin E
Introduction
The role of timing and diversity of allergenic food introduction in the development of childhood allergic sensitization and atopic diseases, such as allergy and eczema, is controversial. Currently, the World Health Organization and the American Academy of Pediatrics recommend not to introduce any complementary foods until age 6 months[1, 2], while the European Academy of Allergy and Clinical Immunology and the European Society for Pediatric Gastroenterology, Hepatology and Nutrition recommend not to avoid or delay the introduction of potentially allergenic foods beyond age 4 months, irrespective of atopic heredity[3, 4].
We previously demonstrated that the introduction of allergenic foods, such as cow's milk and peanut, at age ≤6 months was not associated with eczema until age 4 years[5]. Recently, the LEAP and LEAP-On trials showed that peanut introduction in high-risk children aged 4–11 months was associated with a decreased frequency of peanut allergy at age 5 years that persisted after 12 months of peanut avoidance[6, 7]. This resulted in addendum guidelines for the prevention of peanut allergy in high-risk children, recommending introduction of peanut as early as age 4–6 months in children with severe eczema, egg allergy or both[8]. Another trial did not show an effect of early introduction of six common allergenic foods on the frequency of food allergies between age 1 and 3 years among a selected group of exclusively breast-fed children from the general population[9]. However, less is known about the effects of the timing of introduction of common allergenic foods in early life on allergic sensitization, allergy and eczema in an unselected group of school-age children[10]. Previous birth cohort studies have examined the association of diversity of solid food introduction, by means of the number of solid foods introduced, with allergic sensitization and diseases,[11–15] but none of these studies focused specifically on allergenic foods.
Because animal studies suggest that acquiring immune tolerance is an active process and that exposure to dietary factors during a critical early window at age 4–6 months may be essential to this process[16], we hypothesized that timing and diversity of allergenic food introduction might induce immune tolerance and, subsequently, influence the risk of developing allergic sensitization and atopic diseases in childhood. Therefore, we aimed to examine among 5,202 children participating in a population-based prospective cohort study whether timing and diversity of introduction of allergenic foods (cow's milk, hen's egg, peanut, tree nuts, soy and gluten) were associated with the development of allergic sensitization, inhalant or food allergy and eczema until age 10 years.
Materials and methods
General design
This study was embedded in the Generation R Study, a population-based prospective cohort study from fetal life onwards[17]. The study has been approved by the Medical Ethical Committee of the Erasmus Medical Center, Rotterdam, The Netherlands (MEC-2012-165). Written informed consent was obtained from both parents or legal representatives. A total of 5,202 children were included for the current analyses (S1 Fig).
Allergenic food introduction
We collected data on the introduction of cow's milk, hen's egg, peanut, tree nuts, soy and gluten by parental questionnaires at ages 6 and 12 months ("How often do you give your child cow's milk/hen's egg/peanuts/tree nuts/soy/gluten at present?" and "How old was your child when you first gave it cow's milk/hen's egg/peanuts/tree nuts/soy/gluten?"). Data from the questionnaires were combined and categorized into 'introduction at age ≤6 months' and 'introduction at age >6 months'[5]. In case of inconsistencies between data collected at ages 6 and 12 months, we considered the data collected at age 6 months as the reference, since weaning generally starts around that age[18]. Furthermore, reported introductions of specific allergenic foods were cross-checked with a short food-frequency questionnaire also completed by the mother when the child was 6 and 12 months old.[19] This questionnaire consisted of food products frequently consumed by children around these ages according to a Dutch food consumption survey[18]. For example, if parents indicated that they had never introduced peanut in the child's diet at age 12 months, but at age 6 months parents reported that the child had consumed peanut butter more than once, then the introduction of peanut was considered to be at age ≤6 months. Additionally, the introduction of cow's milk and soy was cross-checked with the type of bottle feeding (regular, soy-based or based on fully or partly hydrolyzed whey protein), and the introduction of gluten was cross-checked with the consumption of specific brands of bread, biscuits and porridge (gluten-containing or gluten-free brands) at ages 6 and 12 months. To assess diversity of allergenic food introduction at age ≤6 months, we categorized the number of allergenic foods introduced at this age into '0', '1', '2' and '≥3'.
Allergic sensitization, allergy and eczema
Children visited the research center at a median age of 9.7 years (2.5–97.5th percentile: 9.3–10.5). Inhalant and food allergic sensitization to house dust mite, 5-grass mixture, birch, cat and dog (ALK-Abelló B.V., Almere, The Netherlands), and hazelnut, cashew nut, peanut and peach were measured by skin prick tests using the scanned area method[20]. Questions adapted from the International Study of Asthma and Allergies in Childhood core questionnaires provided information on physician-diagnosed inhalant ("Was your child ever diagnosed with an allergy to pollen (hay fever)/house dust mite/cat/dog?") (no; yes) and food ("Was your child ever diagnosed with an allergy to cashew nut/peanut?") (no; yes) allergy at age 10 years[21]. We further combined allergic sensitization and physician-diagnosed allergy into groups of 'no allergic sensitization and no allergy', 'any allergic sensitization, but no allergy', 'no allergic sensitization, but any allergy', and 'any allergic sensitization and any allergy'. Physician-diagnosed eczema was parental-reported at ages 6 months and 1, 2, 3, 4 and 10 years ("Was your child diagnosed with eczema in the last 6 months/last year?") (no; yes).
Covariates
Information on maternal age, education (primary or secondary; higher), history of allergy, eczema or asthma (no; yes), parity (nulliparous; multiparous), pet keeping (no; yes) and body mass index (BMI) was obtained by questionnaires completed by the mother at enrollment. Information on maternal smoking (no; yes) was obtained by postal questionnaires multiple times during pregnancy. We assessed maternal psychiatric symptoms in the second trimester of pregnancy using the Global Severity Index of the Brief Symptom Inventory[22]. Information on child's sex, gestational age at birth and birth weight was obtained from obstetric and midwife records at birth. We based ethnic origin (European; non-European) of the child on the country of birth of the parents[23]. Delivery reports and postal questionnaires completed by the mother when the child was 2, 6 and 12 months old provided data on ever breastfeeding (no; yes) and breastfeeding duration (never; <6 months; ≥6 months). We obtained information on ointment use for eczema (no; yes), physician-diagnosed cow's milk allergy (no; yes), day care attendance (no; yes) and antibiotic use (no; yes) by questionnaires at ages 2, 6 and 12 months. BMI was calculated from the child's weight and height measured at age 10–13 months during a visit to the research center.
Statistical analysis
We used logistic regression or multinomial logistic regression models to examine the associations of timing and diversity of allergenic food introduction with the risk of allergic sensitization and physician-diagnosed allergy or combined allergic sensitization and allergy groups, respectively, at age 10 years. We used generalized estimating equation models to examine the associations of timing and diversity of allergenic food introduction with the longitudinal odds of eczema at ages 6 months and 1, 2, 3, 4 and 10 years independently and overall, taking into account correlations between repeated measurements of eczema within the same child[24]. First, we adjusted for potential confounders, including maternal age at enrollment, education, history of allergy, eczema or asthma, parity, pet keeping, BMI at enrollment, smoking, psychiatric symptoms, and child's sex, gestational age, birth weight, ethnic origin, breastfeeding, day care attendance and antibiotic use. We considered this the main model. Second, child's BMI at age 10–13 months was considered as an intermediate and additionally adjusted for in the model. Confounders were included in the models based on literature, if they were associated with both the determinant and the outcome, or if they changed the effect estimates with ≥10%. Analyses with inhalant or food allergic sensitization or allergy as the outcomes were mutually adjusted for each other. Tests for trends were performed by including diversity of allergenic food introduction as a continuous variable in the models. Because the associations evaluated in the current study are complementary and share a single underlying biological hypothesis, we did not apply multiple testing correction[25]. We performed additional analyses to assess the robustness of our results, accounting for disease-related modification of the exposure and effect modification. First, we performed risk period-specific sensitivity analyses by excluding children who developed eczema until age 6 months (n = 928). Second, we additionally adjusted our main model for ointment use for eczema at age 2 months. Third, we tested the modifying effects of maternal history of allergy, eczema or asthma, and child's breastfeeding duration and history of cow's milk allergy until age 1 year, and the time-varying effect of age at eczema measurement by adding them as product terms with the allergenic food variables in the models. Missing data of covariates, allergenic foods and eczema were multiple-imputed to reduce potential bias associated with missing data (S1 Table). The best indicator for the presence or absence of eczema is an eczema measurement at a different age. Therefore, at least one eczema measurement was available in our population for analysis to predict other eczema measurements correctly. Because we lacked repeated measurements on allergic sensitization and physician-diagnosed allergy, we did not impute missing data of these outcomes. The size or direction of the effect estimates did not materially differ between analyses with imputed data and complete cases only (data not shown). Therefore, we present pooled results based on imputed analyses only. Measures of association are presented as adjusted odds ratios (aOR) with their 95% confidence intervals (CI). Statistical analyses were performed using SPSS 21.0.0.1 for Windows (IBM Corp., Armonk, NY, USA) and SAS 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
General
The majority of children were introduced to at least 1 allergenic food (81.8%; n = 4,257) at age ≤6 months, most commonly cow's milk (74.0%; n = 3,847) and gluten (55.8%; 2,904) (Table 1 and S2 Table). Inhalant or food allergic sensitization was present in 31.5% (n = 949) and 6.7% (n = 202) of the children at age 10 years, respectively. Physician-diagnosed inhalant or food allergy was present in 12.0% (n = 435) and 2.3% (n = 81) of the children at age 10 years, respectively. The prevalence of eczema declined from 17.8% (n = 928) at age 6 months to 8.6% (n = 448) at age 10 years. Mothers without follow-up data were younger, lower educated, had higher parity, more often kept pets during pregnancy, had a higher BMI at enrollment, and smoked more and had more psychiatric symptoms during pregnancy. Their children were more often males, born younger, had a lower birth weight, and were more often of non-European origin and less often breastfed and exposed to gluten at age ≤6 months (S3 Table).
Allergenic food introduction
Timing of allergenic food introduction was not associated with allergic sensitization, physician-diagnosed allergy or combined allergic sensitization and allergy groups (Table 2 and S4 Table). Children introduced to gluten at age ≤6 months had a decreased risk of eczema until age 10 years (aOR (95% CI): 0.84 (0.72, 0.99)), compared with children introduced to gluten at age >6 months (Fig 1 and S5 Table). Timing of introduction of other allergenic foods was not associated with eczema at specific ages or overall. Diversity of allergenic food introduction was not associated with allergic sensitization, physician-diagnosed food allergy or combined allergic sensitization and allergy groups (Table 2 and S4 Table). Children introduced to ≥3 allergenic foods at age ≤6 months had a decreased risk of physician-diagnosed inhalant, but not food allergy at age 10 years (0.64 (0.42, 0.98)), compared with children not introduced to any allergenic food at age ≤6 months (Table 2). We did not observe a significant trend for a lower risk of physician-diagnosed inhalant allergy when introduced to a higher number of allergenic foods at age ≤6 months (p = 0.05). Diversity of allergenic food introduction was not consistently associated with eczema (Fig 2 and S5 Table). Additional adjustment for child's BMI at age 10–13 month did not materially affect the size and the direction of the effect estimates (data not shown).
Values are odds ratios (95% confidence interval) from generalized estimating equation models based on imputed data. Reference group is children with allergenic food introduction at age >6 months. Models are adjusted for maternal age at enrollment, education, history of allergy, eczema or asthma, parity, pet keeping, body mass index at enrollment, smoking, psychiatric symptoms, and child's sex, gestational age, birth weight, ethnic origin, breastfeeding, day care attendance and antibiotic use. *P-value <0.05. Mo = months; y = year(s).
Values are odds ratios (95% confidence interval) from generalized estimating equation models based on imputed data. Reference group is children with no allergenic foods introduced at age ≤6 months. Models are adjusted for maternal age at enrollment, education, history of allergy, eczema or asthma, parity, pet keeping, body mass index at enrollment, smoking, psychiatric symptoms, and child's sex, gestational age, birth weight, ethnic origin, breastfeeding, day care attendance and antibiotic use. *P-value <0.05. Mo = months; y = year(s).
Additional analyses
Risk period-specific sensitivity analyses showed that effect estimates for the associations of early gluten introduction with eczema until age 10 years, and of introduction of ≥3 allergenic foods with physician-diagnosed inhalant allergy attenuated to non-significant (0.95 (0.81, 1.10) and 0.65 (0.39, 1.08), respectively). Effect estimates did not materially change in size or direction when we additionally adjusted our main analyses for ointment use for eczema at age 2 months (data not shown). Results were similar among children with and without a maternal history of allergy, eczema or asthma or a history of cow's milk allergy until age 1 year, and we observed no modifying effect of child's breastfeeding duration on any of the examined associations (p-values for interaction >0.05). For egg and gluten introduction, a time-varying effect of age at eczema measurement was observed with stronger associations of egg and gluten introduction with eczema in early than in later life (p-values for interaction <0.05) (Fig 1).
Discussion
In this large prospective population-based study, we observed no consistent association of timing and diversity of allergenic food introduction with allergic sensitization or atopic diseases in children until age 10 years. However, children introduced to gluten at age ≤6 months had a decreased risk of eczema until age 10 years, and children introduced to ≥3 allergenic foods at age ≤6 months had a decreased risk of physician-diagnosed inhalant allergy at age 10 years.
Comparison of main findings with other studies
For the allergenic foods evaluated in the current study, a recent meta-analysis showed no association of early allergenic food introduction with inhalant or food allergic sensitization, measured by skin prick tests or antigen-specific immunoglobulin E (IgE), allergic rhinitis, and eczema[26]. However, introduction of hen's egg at age 4–6 months was associated with a 44% decreased risk of egg allergy at age 1 year, and introduction of peanut at age 4–11 months was associated with a 71% decreased risk of peanut allergy at age 3–5 years. There was no consistent evidence for an association of early cow's milk, tree nuts, soy or gluten introduction with food allergies. Previous birth cohort studies showed inconsistent results on the association of diversity of solid food introduction, by means of the number of solid foods introduced, with the risk of childhood allergic sensitization and atopic diseases[11–15]. However, literature focusing specifically on diversity of allergenic food introduction is lacking. Differences between results from the meta-analysis and the current study might be explained by differences in study population (general population vs. high-risk children; different age groups) and study aim (observational vs. tolerance induction for specific allergenic foods). Other possible explanations may include differences in recall bias, selection of allergenic foods, definitions of diversity of food introduction (solid vs. specific allergenic foods; number of foods per group), outcome methods (antigen-specific IgE vs. skin prick tests; physician-diagnosed vs. parental-reported), child's age at time of outcome measurement and measurement of and adjustment for potential confounders.
Interpretation of results
Dietary factors may serve as substrates for the production of microbial metabolites that regulate immune activity and immune tolerance mechanisms[27]. Therefore, we hypothesized that early allergenic food introduction might influence immune tolerance and, subsequently, the development of childhood allergic sensitization and atopic diseases. However, we found no consistent association of the timing of introduction of allergenic foods with childhood allergic sensitization or atopic diseases. We did find an inverse association of early gluten introduction with eczema, which might be explained by the fact that when gluten are introduced to older children, the amounts tend to be greater than in younger children[28]. We can speculate that a higher gluten load may have resulted in T-cell activation rather than immune tolerance[28]. We observed an association of early gluten introduction with eczema overall but not consistently per year. This might be explained by increased statistical power when using eczema overall rather than a chance finding. Differences in observed associations of allergenic food introduction with eczema and allergic sensitizations or physician-diagnosed allergies might be due to differences in timing of these outcome measurements. Eczema was assessed longitudinally, while allergic sensitizations and physician-diagnosed allergies were measured at one time point only.
It is suggested that exposure to a variety of food products during the first year of life, especially beyond age 6 months, may be important for the development of immune tolerance[13, 14]. Again, we observed no consistent association of diversity of allergenic food introduction with allergic sensitization or atopic diseases. We did observe a suggestive trend for a lower risk of physician-diagnosed inhalant allergy when introduced to a higher (i.e., per 1-food group increase) number of allergenic foods. A recent birth cohort study showed that introduction of a higher number of solid foods was associated with a decreased expression of Cε germline transcript, a marker for antibody isotype switching of B-cells to IgE-producing cells[14]. The inhibition of isotype switching to IgE is one of the mechanisms that might be involved in the inhibition of atopic diseases by regulatory T cells[29]. We did not find an association of diversity of allergenic food introduction with food allergic sensitization and physician-diagnosed food allergy, which could partly be explained by the low prevalence of food allergic sensitization (6.7%) and physician-diagnosed food allergy (2.3%). Therefore, these results should be interpreted with caution.
Our findings might be explained by disease-related modification of the exposure, meaning that early symptoms of allergy or eczema in the child may encourage parents to alter feeding practices. Among children with early allergy-related symptoms and among those with a parental history of allergy, eczema or asthma, introduction of complementary foods, especially allergenic foods, tends to be delayed[14]. We tried to assess the effects of such bias by performing risk period-specific sensitivity analyses and additional adjustment for ointment use at age 2 months. We showed that to some degree disease-related modification of the exposure was present in our study, particularly for the association of early gluten introduction with eczema until age 10 years. Therefore, caution is warranted in interpreting our results, which require further studies for replication and exploration of underlying pathophysiological mechanisms. We found no modifying effects of maternal history of allergy, eczema or asthma and child’s breastfeeding duration and history of cow’s milk allergy until age 1 year.
Strengths and limitations
The strengths of this study are the use of a population-based prospective study design from fetal life onwards with a large number of participants and detailed information on allergic sensitization, allergy and eczema. Also, we adjusted for multiple social, behavioral and environmental factors. However, some methodological limitations should be considered. First, characteristics of non-included subjects differed from those included in the study. Although this may affect the generalizability of our results, it is unlikely that these differences affected the observed associations. Second, our data did not allow us to evaluate the effects of allergenic food introduction during the specific window of immunological opportunity to induce immune tolerance at age 4–6 months. Instead, we assessed the associations of allergenic food introduction at age ≤6 months, which may have underestimated our results. Also, our data did not allow us to evaluate the effects of continued breastfeeding during the period of allergenic food introduction, which may be important for promoting immune tolerance[16]. However, we did not observe any modifying effect of breastfeeding duration. It has recently been suggested that the prevention of food allergy by means of early introduction of multiple allergenic foods is dose-dependent[9], but we lacked data on the precise amounts of allergenic foods introduced. Third, we cannot rule out that our results may be affected by disease-related modification of the exposure. Randomized controlled trials are required to completely exclude this potential bias[14]. Fourth, the short food-frequency questionnaire has previously been validated in our cohort for gluten introduction,[19] but not for the introduction of other allergenic foods. Non-differential misclassification of the timing of allergenic food introduction may have also occurred due to possible exposure of the child to 'hidden' allergenic foods,[30] which may have underestimated our results. To minimize the effect of 'hidden' allergenic food exposure, we performed cross-checks of the reported introductions of specific allergenic foods with a short food-frequency questionnaire consisting of food products, with the type of bottle feeding for the introduction of cow's milk and soy specifically, and with the consumption of specific brands of bread, biscuits and porridge for the introduction of gluten specifically. For measuring allergic sensitization, we selected a panel of common inhalant and food allergens relevant to children of age 10 years. Other allergens, such as milk and egg, were not considered because of low sensitization rates at this age[31]. The scanned area method is recommended in research settings and corrects for interobserver variability and ethnic differences in skin response to histamine[20]. Fifth, we did not perform double blind placebo-controlled food challenges or physical examinations to establish a diagnosis of food allergy or eczema, respectively. This may have led to non-differential misclassification of these outcomes and most probably an underestimation of the observed effects. Instead, we used parental questionnaires with widely accepted and commonly used questions that reliably reflect the prevalence of eczema in young children at the population level[21, 32]. Finally, as in any observational study, residual confounding due to insufficiently or unmeasured confounders might still be present.
In conclusion, we observed no consistent association of timing and diversity of allergenic food introduction with childhood allergic sensitization, physician-diagnosed allergy or eczema. Children introduced to gluten and those introduced to ≥3 allergenic foods at early age had a decreased risk of eczema or physician-diagnosed inhalant allergy, respectively. However, these results do not provide strong evidence to change current feeding guidelines. Further studies are needed to replicate our findings and to explore the specific underlying pathophysiological mechanisms.
Supporting information
S1 Table. Details of the multiple imputation model.
*Also included in the multiple imputation model as indicator variables.
https://doi.org/10.1371/journal.pone.0187999.s002
(DOCX)
S2 Table. Characteristics of mothers and their children (n = 5,202).
Values are *means (SD), †medians (2.5–97.5th percentile) or percentages (absolute numbers) based on observed and imputed data. Data on allergic sensitizations and physician-diagnosed allergies are not imputed.
https://doi.org/10.1371/journal.pone.0187999.s003
(DOCX)
S3 Table. Characteristics of mothers and children included and not included in the study.
Values are *means (SD), †medians (2.5–97.5th percentile) or percentages (absolute numbers) based on observed data. P-values for difference are calculated by independent samples T-test for continuous variables with a normal distribution, the Mann-Whitney U test for continuous variables with a skewed distribution, and Pearson's Chi-square test for categorical variables. Bold values indicate statistical significance at the α = 0.05 level.
https://doi.org/10.1371/journal.pone.0187999.s004
(DOCX)
S4 Table. Associations of timing and diversity of allergenic food introduction with combined allergic sensitization and physician-diagnosed allergy groups in children at age 10 years.
Values are odds ratios (95% confidence interval) from multinomial logistic regression models based on imputed data. Reference group is children without any allergic sensitization or physician-diagnosed allergy (n = 1,759), and with *allergenic food introduction at age >6 months or †no allergenic foods introduced at age ≤6 months. Models are adjusted for maternal age at enrollment, education, history of allergy, eczema or asthma, parity, pet keeping, body mass index at enrollment, smoking, psychiatric symptoms, and child's sex, gestational age, birth weight, ethnic origin, breastfeeding, day care attendance and antibiotic use. N.A. = not available due to low number of children.
https://doi.org/10.1371/journal.pone.0187999.s005
(DOCX)
S5 Table. Associations of timing and diversity of allergenic food introduction with eczema per year and overall in children until age 10 years.
Values are odds ratios (95% confidence interval) from generalized estimating equation models based on imputed data. Bold values indicate statistical significance at the α = 0.05 level. Reference group is children without any allergic sensitization or physician-diagnosed allergy, and with *allergenic food introduction at age >6 months or †no allergenic foods introduced at age ≤6 months. Models are adjusted for maternal age at enrollment, education, history of allergy, eczema or asthma, parity, pet keeping, body mass index at enrollment, smoking, psychiatric symptoms, and child's sex, gestational age, birth weight, ethnic origin, breastfeeding, day care attendance and antibiotic use.
https://doi.org/10.1371/journal.pone.0187999.s006
(DOCX)
Acknowledgments
The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the School of Law and Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, Rotterdam, the Rotterdam Homecare Foundation, Rotterdam and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR-MDC), Rotterdam. We gratefully acknowledge the contribution of children and parents, general practitioners, hospitals, midwives and pharmacies in Rotterdam.
References
- 1.
Dewey KG. Guiding principles for complementary feeding of the breastfed child. Washington D.C.: Pan American Health Organization/World Health Organization, 2003.
- 2. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827–41. pmid:22371471
- 3. Muraro A, Halken S, Arshad SH, Beyer K, Dubois AE, Du Toit G, et al. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy. 2014;69(5):590–601. pmid:24697491
- 4. Fewtrell M, Bronsky J, Campoy C, Domellöf M, Embleton N, Fidler Mis N, et al. Complementary feeding: a position paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2017;64(1):119–32. pmid:28027215
- 5. Tromp II, Kiefte-de Jong JC, Lebon A, Renders CM, Jaddoe VW, Hofman A, et al. The introduction of allergenic foods and the development of reported wheezing and eczema in childhood: the Generation R study. Arch Pediatr Adolesc Med. 2011;165(10):933–8. pmid:21646571
- 6. Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372(9):803–13. pmid:25705822
- 7. Du Toit G, Sayre PH, Roberts G, Sever ML, Lawson K, Bahnson HT, et al. Effect of avoidance on peanut allergy after early peanut consumption. N Engl J Med. 2016;374(15):1435–43. pmid:26942922
- 8. Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR Jr., Beck LA, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. J Allergy Clin Immunol. 2017;139(1):29–44. pmid:28065278
- 9. Perkin MR, Logan K, Tseng A, Raji B, Ayis S, Peacock J, et al. Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants. N Engl J Med. 2016;374(18):1733–43. pmid:26943128
- 10. Nwaru BI, Craig LC, Allan K, Prabhu N, Turner SW, McNeill G, et al. Breastfeeding and introduction of complementary foods during infancy in relation to the risk of asthma and atopic diseases up to 10 years. Clin Exp Allergy. 2013;43(11):1263–73. pmid:24152159
- 11. Morgan J, Williams P, Norris F, Williams CM, Larkin M, Hampton S. Eczema and early solid feeding in preterm infants. Arch Dis Child. 2004;89(4):309–14. pmid:15033836
- 12. Nwaru BI, Takkinen HM, Niemelä O, Kaila M, Erkkola M, Ahonen S, et al. Introduction of complementary foods in infancy and atopic sensitization at the age of 5 years: timing and food diversity in a Finnish birth cohort. Allergy. 2013;68(4):507–16. pmid:23510377
- 13. Nwaru BI, Takkinen HM, Kaila M, Erkkola M, Ahonen S, Pekkanen J, et al. Food diversity in infancy and the risk of childhood asthma and allergies. J Allergy Clin Immunol. 2014;133(4):1084–91. pmid:24472626
- 14. Roduit C, Frei R, Depner M, Schaub B, Loss G, Genuneit J, et al. Increased food diversity in the first year of life is inversely associated with allergic diseases. J Allergy Clin Immunol. 2014;133(4):1056–64. pmid:24508301
- 15. Zutavern A, Brockow I, Schaaf B, von Berg A, Diez U, Borte M, et al. Timing of solid food introduction in relation to eczema, asthma, allergic rhinitis, and food and inhalant sensitization at the age of 6 years: results from the prospective birth cohort study LISA. Pediatrics. 2008;121(1):e44–52. pmid:18166543
- 16. Prescott SL, Smith P, Tang M, Palmer DJ, Sinn J, Huntley SJ, et al. The importance of early complementary feeding in the development of oral tolerance: concerns and controversies. Pediatr Allergy Immunol. 2008;19(5):375–80. pmid:18266825
- 17. Kooijman MN, Kruithof CJ, van Duijn CM, Duijts L, Franco OH, van IJzendoorn MH, et al. The Generation R Study: design and cohort update 2017. Eur J Epidemiol. 2016;31(12):1243–64. pmid:28070760
- 18.
Breedveld BC, Hulshof KF. [Zo eten jonge peuters in Nederland 2002. Resultaten van het Voedingsstoffen Inname Onderzoek 2002]. The Hague: Netherlands Nutrition Centre, 2002.
- 19. Hopman EG, Kiefte-de Jong JC, le Cessie S, Moll HA, Witteman JC, Bleeker SE, et al. Food questionnaire for assessment of infant gluten consumption. Clin Nutr. 2007;26(2):264–71. pmid:17316924
- 20. van der Valk JP, Gerth van Wijk R, Hoorn E, Groenendijk L, Groenendijk IM, de Jong NW. Measurement and interpretation of skin prick test results. Clin Transl Allergy. 2015;6:8. pmid:26909142
- 21. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8(3):483–91. pmid:7789502
- 22.
Derogatis LR. BSI brief symptom inventory: administration, scoring, and procedures manual (4th ed.). Minneapolis, MN: National Computer Systems; 1993.
- 23.
Statistics Netherlands. Annual report on integration 2014. The Hague/Heerlen: Statistics Netherlands, 2014.
- 24. Twisk JW. Different statistical models to analyze epidemiological observational longitudinal data: an example from the Amsterdam Growth and Health Study. Int J Sports Med. 1997;18 Suppl 3:S216–24.
- 25. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43–6. pmid:2081237
- 26. Ierodiakonou D, Garcia-Larsen V, Logan A, Groome A, Cunha S, Chivinge J, et al. Timing of Allergenic Food Introduction to the Infant Diet and Risk of Allergic or Autoimmune Disease: A Systematic Review and Meta-analysis. JAMA. 2016;316(11):1181–92. pmid:27654604
- 27. Frei R, Lauener RP, Crameri R, O'Mahony L. Microbiota and dietary interactions: an update to the hygiene hypothesis? Allergy. 2012;67(4):451–61. pmid:22257145
- 28. Poole JA, Barriga K, Leung DY, Hoffman M, Eisenbarth GS, Rewers M, et al. Timing of initial exposure to cereal grains and the risk of wheat allergy. Pediatrics. 2006;117(6):2175–82. pmid:16740862
- 29. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol. 2003;3(9):721–32. pmid:12949496
- 30. Martín-Muñnoz MF, Pineda F, García Parrado G, Guillén D, Rivero D, Belver T, et al. Food allergy in breastfeeding babies. Hidden allergens in human milk. Eur Ann Allergy Clin Immunol. 2016;48(4):123–8. pmid:27425167
- 31. Roberts G, Zhang H, Karmaus W, Raza A, Scott M, Matthews S, et al. Trends in cutaneous sensitization in the first 18 years of life: results from the 1989 Isle of Wight birth cohort study. Clin Exp Allergy. 2012;42(10):1501–9. pmid:22994347
- 32. Flohr C, Weinmayr G, Weiland SK, Addo-Yobo E, Annesi-Maesano I, Björkstén B, et al. How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol. 2009;161(4):846–53. pmid:19485999